Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 123Precursor Cell Lymphoblastic Leukemia-Lymphoma 105Myelodysplastic Syndromes 101Lymphoma, Non-Hodgkin 94Leukemia, Lymphocytic, Chronic, B-Cell 94Hodgkin Disease 88Multiple Myeloma 82Leukemia 73Lymphoma, Mantle-Cell 63Lymphoma, Follicular 62Lymphoma 62Lymphoma, Large B-Cell, Diffuse 59Myeloproliferative Disorders 55Lymphoma, B-Cell, Marginal Zone 55Leukemia, Myelogenous, Chronic, BCR-ABL Positive 54Burkitt Lymphoma 50Leukemia, Myelomonocytic, Chronic 48Congenital Abnormalities 46Leukemia, Myeloid, Chronic-Phase 45Lymphoma, Large-Cell, Immunoblastic 42Leukemia, Myeloid, Accelerated Phase 39Anemia, Refractory, with Excess of Blasts 36Hematologic Neoplasms 35Waldenstrom Macroglobulinemia 34Primary Myelofibrosis 34Graft vs Host Disease 34Blast Crisis 31Neoplasms, Plasma Cell 30Recurrence 28Dendritic Cell Sarcoma, Interdigitating 28

Interventions

Cyclophosphamide 53Etoposide 33Temozolomide 28Irinotecan 28Melphalan 25Filgrastim 25Topotecan 24Carboplatin 243-Iodobenzylguanidine 23Isotretinoin 20Granulocyte Colony-Stimulating Factor 17sargramostim 16humanized 3F8 anti-GD2 monoclonal antibody 16dinutuximab 16Granulocyte-Macrophage Colony-Stimulating Factor 16fludarabine 15Vincristine 15Doxorubicin 15Cisplatin 15Peripheral Blood Stem Cell Transplantation 14Interleukin-2 14Busulfan 13naxitamab 12Thiotepa 12Radiotherapy 12aldesleukin 11fludarabine phosphate 10etoposide phosphate 8Mesna 8Ifosfamide 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Neuroblastoma × Mycophenolic Acid × Clear all
NCT04530487 2025-06-29

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 7 charts
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Neurofibrosarcoma, Desmoplastic Small Round Cell Tumor

NCT05303727 2022-07-01

Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Not yet recruiting
64 enrolled
CNS

Neuroblastoma

NCT00874315 2015-10-16

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

Nationwide Children's Hospital

Phase 2 Withdrawn
CNS

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡